User profiles for Teresa Guerrero Urbano
 | guerrero urbano teresaConsultant Clinical Oncologist, Guy's and St Thomas NHS Trust Verified email at gstt.nhs.uk Cited by 908 |
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
…, JP Morden, KJ Harrington, TG Urbano… - The lancet …, 2011 - thelancet.com
Background Xerostomia is the most common late side-effect of radiotherapy to the head and
neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) …
neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) …
Clinical update on cancer: molecular oncology of head and neck cancer
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are
biologically aggressive in nature. These cancers remain difficult to treat and treatment can …
biologically aggressive in nature. These cancers remain difficult to treat and treatment can …
Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck …
…, SE Papa, JP Jeannon, TG Urbano… - Human gene therapy …, 2013 - liebertpub.com
Despite several advances, 5-year survival in patients with head and neck squamous cell
carcinoma (HNSCC) remains unchanged at only 50%. The commonest cause of death is locally …
carcinoma (HNSCC) remains unchanged at only 50%. The commonest cause of death is locally …
MicroRNA‐196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance
…, N Raulf, J Gäken, K Lawler, TG Urbano… - … journal of cancer, 2015 - Wiley Online Library
Radiotherapy is a major treatment modality for head and neck squamous cell carcinoma (HNSCC).
Up to 50% of patients with locally advanced disease relapse after radical treatment …
Up to 50% of patients with locally advanced disease relapse after radical treatment …
Presenting pre-radiotherapy dental status of head and neck cancer patients in the novel radiation era
…, M McGurk, I Sassoon, T Guerrero Urbano… - British dental …, 2020 - nature.com
Objectives Dental assessment remains a key intervention for head and neck cancer (HNC)
patients pre-radiotherapy (RT). The purpose of this study was to identify the variation in …
patients pre-radiotherapy (RT). The purpose of this study was to identify the variation in …
Analysis of loco-regional failures in head and neck cancer after radical radiation therapy
…, S Barrington, A Pathmanathan, M Lei, TG Urbano - Oral oncology, 2015 - Elsevier
Objectives To investigate the anatomical distribution of loco-regional treatment failures (LRF)
in patients with head and neck squamous cell carcinoma (HNSCC) in relation to clinical …
in patients with head and neck squamous cell carcinoma (HNSCC) in relation to clinical …
A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC).
…, D Davies, F Farzaneh, T Guerrero Urbano… - 2018 - ascopubs.org
3046 Background: Recent FDA approvals make CAR T-cell therapy a clinical reality for
hematologic malignancy. Toxicity and antigen loss-mediated resistance remain problematic. …
hematologic malignancy. Toxicity and antigen loss-mediated resistance remain problematic. …
A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer
TG Urbano, CH Clark, VN Hansen, EJ Adams… - Radiotherapy and …, 2007 - Elsevier
BACKGROUND AND PURPOSE: Intensity modulated radiotherapy (IMRT) allows the delivery
of higher and more homogeneous radiation dose to head and neck tumours. This study …
of higher and more homogeneous radiation dose to head and neck tumours. This study …
Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas' Head and Neck Cancer Unit …
…, R Oakley, JP Jeannon, M Lei, TG Urbano - Oral surgery, oral …, 2016 - Elsevier
… FRCS e , Mark McGurk FRCS f , Ricard Simo FRCS f , Andrew Lyons MS f , Richard Oakley
FDSRCS f , Jean-Pierre Jeannon FRCS f , Mary Lei PhD a , Teresa Guerrero Urbano PhD a …
FDSRCS f , Jean-Pierre Jeannon FRCS f , Mary Lei PhD a , Teresa Guerrero Urbano PhD a …
[HTML][HTML] The microbiota and radiotherapy for head and neck cancer: What should clinical oncologists know?
MR Ferreira, A Pasto, T Ng, V Patel, TG Urbano… - Cancer Treatment …, 2022 - Elsevier
Radiotherapy is a linchpin in head and neck squamous cell carcinoma (HN-SCC) treatment.
Modulating tumour and/or normal tissue biology offers opportunities to further develop HN-…
Modulating tumour and/or normal tissue biology offers opportunities to further develop HN-…
